Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
37.71B | 31.76B | 32.92B | 23.09B | 31.98B | 31.08B | Gross Profit |
41.89B | 31.76B | 33.95B | 23.09B | 31.98B | 31.08B | EBIT |
13.01B | 0.00 | 1.03B | -1.62B | 97.00M | 2.88B | EBITDA |
-784.00M | 1.58B | 2.43B | -2.73B | 1.36B | 2.61B | Net Income Common Stockholders |
1.33B | 683.00M | 1.08B | -1.18B | 416.00M | 2.06B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
15.93B | 23.48B | 17.27B | 22.50B | 12.48B | 16.90B | Total Assets |
429.52B | 353.88B | 328.84B | 302.26B | 343.44B | 466.52B | Total Debt |
9.98B | 6.89B | 7.37B | 8.57B | 8.42B | 11.13B | Net Debt |
-5.94B | -16.59B | -9.91B | -13.94B | -4.06B | -5.78B | Total Liabilities |
9.17B | 345.26B | 319.24B | 289.86B | 323.99B | 445.96B | Stockholders Equity |
17.49B | 8.30B | 8.79B | 12.09B | 19.20B | 19.55B |
Cash Flow | Free Cash Flow | ||||
-1.26B | 8.27B | -3.08B | 3.85B | 3.19B | 8.91B | Operating Cash Flow |
-942.00M | 8.45B | -2.73B | 3.95B | 3.30B | 9.05B | Investing Cash Flow |
10.00M | 162.00M | -350.00M | 11.13B | -6.58B | -12.70B | Financing Cash Flow |
-1.69B | -2.49B | -1.82B | -5.47B | -3.91B | -339.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £13.31B | 21.21 | 5.48% | 6.89% | -1.13% | -38.11% | |
80 Outperform | £9.25B | 13.95 | 56.17% | 4.07% | 34.86% | 95.18% | |
64 Neutral | $13.21B | 9.26 | 9.39% | 4.87% | 16.14% | -8.87% | |
63 Neutral | £3.47B | 23.76 | 5.97% | 2.25% | 26.11% | -29.43% | |
62 Neutral | £5.13B | ― | -60.34% | 9.92% | -6.33% | ― | |
53 Neutral | £12.65B | 75.40 | 4.06% | 9.06% | -21.56% | -61.14% |